A Clinical Study to evaluate the Safety and Efficacy of ACELABS Lumiere Rebalancing Diamond Drop for advanced skin brightening. - NI

Bright Diva Pte. Ltd.0 个研究点目标入组 0 人开始时间: 待定最近更新: 2024年3月4日

试验速览

暂无简介。

•1.Gender: Male or Female aged between 20 to 30, with minimum F:M distribution ratio of 2:1
•2.Subject willing to give written informed consent
•3.Women of child bearing potential must have a negative urine pregnancy test
•4.Free of any systemic and dermatologic disorder, which in the opinion of the investigator, will interface with the study results or increase the risk of AE.
•5.Are willing to avoid prolonged exposure of the treatment area to ultraviolet radiation (natural or artificial) for the duration of the study.

•1.Subjects who are pregnant, breast feeding, or planning to become pregnant during the study
•2.Have any evidence of systematic cancer, squamous cell carcinoma, basal cell carcinoma in the last 5 years, or any other confounding skin condition.
•3.Have open sore or open lesions in the treatment area
•4.Have any condition that, in the opinion of the investigator, would confound the safety and efficacy assessments of the product.
•5.Have participated in any interventional clinical trial in the previous 30 days.
•6.Have a known sensitivity to any of the constituents of the test product including sensitivities to any of the constituents.
•7.Have used, are using, or are planning to use immunosuppressive or immunomodulatory medications (i.e., biologics), blood purifiers and including corticosteroids.
•8.Have a history of alcohol or illegal drug/ substance abuse or suspected alcohol or illegal drug/substance abuse in the past 2 years.

发起方

Bright Diva Pte. Ltd.